Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 23, 1999
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathologyC A Gutekunst, S H Li, H Yi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesisS Holbert, I Denghien, T Kiechle, et al.
Neurology|October 16, 1999
Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathyJ M Shefner, A G Reaume, D G Flood, et al.
Nature Medicine|March 23, 1999
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosisP Klivenyi, R J Ferrante, R T Matthews, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1993
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acidM F Beal, E Brouillet, B G Jenkins, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1995
Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivoJ B Schulz, R T Matthews, B G Jenkins, et al.
Neurology|March 13, 2002
Regional and progressive thinning of the cortical ribbon in Huntington's diseaseH D Rosas, A K Liu, S Hersch, et al.
Annals of Neurology|July 18, 2001
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's diseaseO A Andreassen, R J Ferrante, H M Huang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 15, 1997
Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out miceC Ayata, G Ayata, H Hara, et al.
Neurobiology of Disease|July 13, 2001
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's diseaseO A Andreassen, A Dedeoglu, R J Ferrante, et al.
Pageof 9